Giving Compass' Take:
- Research reports that 38% of more than 460,000 women who gave birth during the pandemic have increasingly filled opioid prescriptions.
- How can this research help guide donor capital to populations that need it? What are the long-term impacts for women who are touched by the opioid crisis?
- Read about the role of philanthropy in addressing the opioid crisis.
What is Giving Compass?
We connect donors to learning resources and ways to support community-led solutions. Learn more about us.
Women who gave birth during the COVID-19 pandemic filled significantly more prescriptions for opioid medications, researchers report.
A new study found that 38% of more than 460,000 women who gave birth from July 2018 through December 2020 received a prescription for opioids, but there was a significant increase in the number of prescriptions filled for women giving birth during COVID.
The opioids they were prescribed were also higher strength than those given to women who gave birth prior to the pandemic.
“A lot of women receive opioids for treatment of pain during the postpartum period, but they are a particularly vulnerable group because many of them haven’t used opioid medications before,” says Emily Lawler, an assistant professor in the School of Public and International Affairs at the University of Georgia and a coauthor of the study in JAMA Network Open. “That makes them high risk for potential opioid abuse.”
The findings are especially concerning given the uptick in opioid overdose deaths during the pandemic, when they surpassed 100,000 deaths annually, the researchers say.
The American College of Obstetrics and Gynecology recommends health care providers use a stepwise approach to pain management for postpartum mothers. First, they start with a basic pain reliever like ibuprofen or acetaminophen. If that doesn’t alleviate the pain, physicians move to a low strength opioid, such as codeine or tramadol.
But the association also recommends that those prescribed opioids not take them for extended periods and be switched to over-the-counter pain medications as soon as possible.
“Prior to the pandemic, opioid prescriptions were decreasing not only in terms of the number of women prescribed opioids but also the strength of the opioids being prescribed and the number of days covered by each prescription,” says lead author Shelby Steuart, a doctoral candidate in the School of Public and International Affairs.
“But right after the COVID-19 lockdowns happen in March 2020, we saw a sharp spike in opioid prescription fills,” she continues. “We don’t know whether physicians were writing more opioid prescriptions or if more women were just taking their prescriptions to the pharmacy and filling them, but it is concerning.”
It’s possible physicians were concerned that they wouldn’t see their patients as frequently during the lockdown and COVID surges and were attempting to compensate for that, the researchers say. But it’s also possible that the anxiety from the pandemic exacerbated women’s feelings of pain, prompting them to fill their prescriptions when they may not have prior to the COVID-19 outbreak.
Read the full article about women's opioid prescriptions by Leigh Beeson at Futurity.